Crescita Therapeutics Inc. announced that Board appointed Ms. Deborah Shannon-Trudeau as an independent non-executive director effective November 10, 2021. Ms. Shannon-Trudeau has over 30 years? experience in strategy, business development, commercial and manufacturing operations. Formerly, she was Senior Vice-President Licensing and International Business at Trudeau Corporation. Ms. Trudeau is Vice-Chair of the Board and Chair of the Governance Committee of the Royal Canadian Mint. In parallel, she serves on the Board of CORIM.